Ensign Group, Inc (ENSG) is a leading American-based company that specializes in offering a broad spectrum of healthcare services. Incorporated in 1999 and headquartered in San Juan Capistrano, California, the company stands out in fields such as skilled nursing, rehabilitative care centers, and home health care assistance. It serves the needs of many under the guidance of its dynamic, proactive management and dedicated staff.
ENSG operations fall under two main divisions. The Transitional & Skilled Services segment provides a comprehensive range of medical, nursing, rehabilitative, pharmacy, and routine services. The team in this division is proficient in handling post-acute patients and takes care of their full recovery. It is strongly focused on maintaining quality in every facet of their services. The quality of services at Ensign Group allows for faster recovery and better health outcomes for patients.
The second division, Home Health & Hospice Services, primarily focuses on providing home health, hospice, and home care businesses at over 80 operations in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Oregon, Texas, Utah, Washington, and Wisconsin. The division's goal is to enable patients to receive care at the comfort of their home by providing a wide range of medical and therapeutic services.
ENSG prides itself on having a Patient-Centered, Outcome-Focused, Locally-Delivery business model, which has made the company a popular choice among customers. It also runs retirement communities to provide accommodation and related services. Furthermore, the company’s innovative approach to dealing with the various aspects of healthcare services reflects positively on their overall patient satisfaction.
Financially, Ensign Group, Inc is a for-profit company, with its shares listed on NASDAQ under the ticker symbol “ENSG.” Over the years, the firm has seen steady growth rates, evidencing the market’s trust in its quality of care and services. The company has also gained recognition for stringently adhering to regulatory compliance, affordable pricing, and care efficiency.
Ensign Group, Inc has been committed to transforming healthcare services, setting new standards, and enhancing the quality of life of its patients. The company’s ethos of going the extra mile for each one of their patients has not only positioned it as a leader in the healthcare landscape in the United States but has also made an indelible imprint in the hearts of the patients they serve.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
The Ensign Group is approaching its third-quarter earnings report with analysts expecting strong growth in earnings and revenue. The key question is whether its mature facilities can generate enough growth to offset the drag from recently acquired low-occupancy buildings in Texas. Investors will be closely watching for sustained same-store growth, stable margins, and a reaffirmed or raised outlook to maintain confidence in the company's compounding execution.
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against The Ensign Group, Inc. (NASDAQ: ENSG) on behalf of investors who purchased Ensign securities between February 10, 2022, and June 18, 2026. The lawsuit alleges that Ensign's business model systematically neglects elderly residents in its facilities, defrauds Medicaid and Medicare, and made false and misleading statements about its operations. Investors are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.
Bernstein Liebhard LLP has issued a shareholder alert for investors of The Ensign Group, Inc. (ENSG), reminding them of an upcoming December 7, 2026, deadline to join a securities fraud class action lawsuit. The lawsuit alleges that Ensign made materially false and misleading statements regarding its business and financial stability between February 10, 2022, and June 18, 2026, causing investors significant losses. Affected investors are encouraged to contact the firm to learn more about joining the class action or serving as lead plaintiff.
Kaplan Fox & Kilsheimer LLP has announced a class action lawsuit against The Ensign Group, Inc. (NASDAQ: ENSG) on behalf of investors who purchased securities between February 10, 2022, and June 18, 2026. The lawsuit alleges that Ensign's business model involves systematic neglect of elderly patients, fraudulent billing of Medicaid and Medicare, and falsification of records. Investors have until December 7, 2026, to move the court to seek a lead plaintiff role in the class action.
Kahn Swick & Foti, LLC (KSF) has announced a class action securities lawsuit against The Ensign Group, Inc. (NasdaqGS: ENSG), accusing the company of making materially false and misleading statements and systematically neglecting elderly patients. Investors who purchased Ensign securities between February 10, 2022, and June 18, 2026, have until December 7, 2026, to apply to be a lead plaintiff. The lawsuit alleges Ensign's business model relies on widespread neglect, fraudulent practices with Medicaid and Medicare, and other illegal schemes.